Predictions
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€713.00
17.05.24
17.05.24
€900.00
17.05.25
17.05.25
-0.60%
17.05.24
17.05.24
Could be worthwhile Investment >10% per year
Known brand
Medium risks for its business
overvalued
Johnson & Johnson
Start price
Target price
Perf. (%)
€141.42
16.05.24
16.05.24
€160.88
16.05.25
16.05.25
0.59%
17.05.24
17.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€899.00
16.05.24
16.05.24
-
16.05.25
16.05.25
0.51%
17.05.24
17.05.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€909.80
14.05.24
14.05.24
€1,064.2
14.05.25
14.05.25
-0.68%
17.05.24
17.05.24
Biogen Inc.
Start price
Target price
Perf. (%)
€205.20
12.05.24
12.05.24
€207.00
12.05.25
12.05.25
3.36%
17.05.24
17.05.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€393.70
11.05.24
11.05.24
-
11.05.25
11.05.25
4.03%
17.05.24
17.05.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.70
07.05.24
07.05.24
€428.60
07.05.25
07.05.25
10.18%
17.05.24
17.05.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.70
07.05.24
07.05.24
€423.03
07.05.25
07.05.25
10.18%
17.05.24
17.05.24
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.10
06.05.24
06.05.24
€199.37
06.05.25
06.05.25
3.01%
17.05.24
17.05.24
Amgen Inc.
Start price
Target price
Perf. (%)
€287.40
06.05.24
06.05.24
€295.00
06.05.25
06.05.25
0.75%
17.05.24
17.05.24
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€373.05
04.05.24
04.05.24
-
04.05.25
04.05.25
9.78%
17.05.24
17.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
-2.31%
17.05.24
17.05.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.10
01.05.24
01.05.24
-
01.05.25
01.05.25
-1.47%
17.05.24
17.05.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€842.40
01.05.25
01.05.25
-2.31%
17.05.24
17.05.24
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€60.80
01.05.24
01.05.24
€79.54
01.05.25
01.05.25
2.48%
17.05.24
17.05.24